Literature DB >> 16986106

Apparent diffusion coefficient histograms may predict low-grade glioma subtype.

Daniel J Tozer1, H Rolf Jäger, Nasuda Danchaivijitr, Christopher E Benton, Paul S Tofts, Jeremy H Rees, Adam D Waldman.   

Abstract

The subtypes of glioma are known to have different prognosis and response to treatment. The purpose of this work was to investigate whether apparent diffusion coefficient (ADC) histograms of untreated low-grade astrocytomas and oligodendrogliomas exhibit different characteristics due to their biological differences, and whether a diagnosis of tumour subtype can be made at presentation using the histogram alone, which, if possible, would have an impact on clinical practise. Fifteen patients with astrocytoma (AC) [11 male (mean age +/- standard deviation) 40 +/- 11 years], nine with oligodendroglioma (OD) (four male, 45 +/- 13 years) and three with oligoastrocytoma (OA) (two male, 60 +/- 11 years) were recruited and diffusion-weighted images (b = 0 and 1000 s mm(-2)) were acquired every 6 months to date or until malignant transformation. Whole tumour ADC histograms were calculated, a multiple discriminant analysis was performed and quantitative morphological parameters extracted, the AC and OD subtypes were then compared using Student's unpaired t-test. Classification of the histograms was also performed. ODs had significantly lower group ADC values than ACs and up to 83% of the subjects could be correctly classified into the OD and AC groups by reference to the histogram. The group differences were most significant for the multiple discriminant analysis (p = 1 x 10(-5)) and at the 10th centile point [AC = 1170 +/- 170, OD = (1030 +/- 80) x 10(-6) mm(2) s(-1)] (p = 0.01). ODs have a lower ADC than ACs with differences throughout the histogram. Both tumour types show similar intra-tumour heterogeneity, as seen from the equal group peak heights, but ACs shows more intra-group heterogeneity. ADC histogram analysis may aid non-invasive sub-classification of low-grade glioma histological subtypes.

Entities:  

Mesh:

Year:  2007        PMID: 16986106     DOI: 10.1002/nbm.1091

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  60 in total

Review 1.  Current concepts in the evaluation and management of WHO grade II gliomas.

Authors:  Joseph M Piepmeier
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

2.  Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.

Authors:  C H Suh; H S Kim; Y J Choi; N Kim; S J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-04       Impact factor: 3.825

3.  Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.

Authors:  Rihyeon Kim; Seung Hong Choi; Tae Jin Yun; Soon-Tae Lee; Chul-Kee Park; Tae Min Kim; Ji-Hoon Kim; Sun-Won Park; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim
Journal:  Eur Radiol       Date:  2016-06-29       Impact factor: 5.315

4.  Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.

Authors:  Csaba Juhász; Otto Muzik; Diane C Chugani; Harry T Chugani; Sandeep Sood; Pulak K Chakraborty; Geoffrey R Barger; Sandeep Mittal
Journal:  J Neurooncol       Date:  2010-07-30       Impact factor: 4.130

Review 5.  Genetics and imaging of oligodendroglial tumors.

Authors:  Jonathan R Ellenbogen; Carol Walker; Michael D Jenkinson
Journal:  CNS Oncol       Date:  2015-10-19

Review 6.  Imaging ovarian cancer and peritoneal metastases--current and emerging techniques.

Authors:  Stavroula Kyriazi; Stan B Kaye; Nandita M deSouza
Journal:  Nat Rev Clin Oncol       Date:  2010-04-13       Impact factor: 66.675

7.  Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.

Authors:  Wei Bian; Inas S Khayal; Janine M Lupo; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

8.  Relationship between choline and apparent diffusion coefficient in patients with gliomas.

Authors:  Inas S Khayal; Forrest W Crawford; Suja Saraswathy; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Tracy R McKnight; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

9.  Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma.

Authors:  Susan M Chang; Sarah Nelson; Scott Vandenberg; Soonmee Cha; Michael Prados; Nicholas Butowski; Michael McDermott; Andrew T Parsa; Manish Aghi; Jennifer Clarke; Mitchel Berger
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

10.  Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype.

Authors:  Michael D Jenkinson; Daniel G du Plessis; Trevor S Smith; Andrew R Brodbelt; Kathy A Joyce; Carol Walker
Journal:  J Neurooncol       Date:  2009-07-19       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.